These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2325635

  • 1. KT5926, a potent and selective inhibitor of myosin light chain kinase.
    Nakanishi S, Yamada K, Iwahashi K, Kuroda K, Kase H.
    Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain.
    Sullivan JP, Connor JR, Shearer BG, Burch RM.
    Mol Pharmacol; 1992 Jan; 41(1):38-44. PubMed ID: 1732721
    [Abstract] [Full Text] [Related]

  • 9. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
    Kim YS, Kawai A.
    Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW, Crimmins DL, Thoma RS, Garcia JG.
    Arch Biochem Biophys; 1996 Aug 01; 332(1):101-9. PubMed ID: 8806714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential regulation of phospholipase A2 (PLA2)-dependent Ca2+ signaling in smooth muscle by cAMP- and cGMP-dependent protein kinases. Inhibitory phosphorylation of PLA2 by cyclic nucleotide-dependent protein kinases.
    Murthy KS, Makhlouf GM.
    J Biol Chem; 1998 Dec 18; 273(51):34519-26. PubMed ID: 9852121
    [Abstract] [Full Text] [Related]

  • 15. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ.
    Rev Clin Basic Pharm; 1985 Dec 18; 5(3-4):341-95. PubMed ID: 3029813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of protein phosphorylation in Ca2+ regulated intracellular messenger systems.
    Hidaka H, Hagiwara M, Ishikawa T, Saitoh M.
    Microcirc Endothelium Lymphatics; 1989 Dec 18; 5(1-2):13-29. PubMed ID: 2677639
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase.
    Nishikawa M, Komada F, Morita K, Deguchi K, Shirakawa S.
    Cell Signal; 1992 Jul 18; 4(4):453-63. PubMed ID: 1329900
    [Abstract] [Full Text] [Related]

  • 20. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
    Silver PJ, Stull JT.
    Mol Pharmacol; 1983 May 18; 23(3):665-70. PubMed ID: 6688120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.